Vemurafenib Not Yet Recruiting Phase 2 Trials for Melanoma, Malignant, of Soft Parts Treatment

IndicationsStatusPurposePhase
Not Yet RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02968303Induction Therapy With Vemurafenib and Cobimetinib to Optimize Nivolumab and Ipilimumab Therapy